전일 마감가:
$25.90
열려 있는:
$25.89
하루 거래량:
51.91M
Relative Volume:
1.31
시가총액:
$149.04B
수익:
$63.63B
순이익/손실:
$8.03B
주가수익비율:
18.65
EPS:
1.41
순현금흐름:
$8.23B
1주 성능:
+3.02%
1개월 성능:
-1.28%
6개월 성능:
-9.40%
1년 성능:
-4.95%
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PFE
Pfizer Inc
|
26.30 | 149.04B | 63.63B | 8.03B | 8.23B | 1.41 |
![]()
LLY
Lilly Eli Co
|
873.68 | 830.35B | 45.04B | 10.59B | 414.30M | 11.71 |
![]()
NVO
Novo Nordisk Adr
|
88.08 | 390.99B | 42.09B | 14.65B | 10.11B | 3.2833 |
![]()
ABBV
Abbvie Inc
|
202.08 | 356.74B | 56.33B | 4.28B | 17.83B | 2.40 |
![]()
JNJ
Johnson Johnson
|
162.30 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
![]()
MRK
Merck Co Inc
|
89.50 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
화이자 Stock (PFE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-10 | 재개 | BofA Securities | Neutral |
2024-11-15 | 개시 | Wolfe Research | Underperform |
2024-10-25 | 재개 | Citigroup | Neutral |
2024-10-17 | 개시 | Bernstein | Mkt Perform |
2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
2024-02-23 | 개시 | Guggenheim | Buy |
2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
2023-10-20 | 재개 | UBS | Neutral |
2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
2023-07-17 | 재확인 | JP Morgan | Neutral |
2023-07-14 | 개시 | HSBC Securities | Buy |
2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
2023-03-06 | 개시 | Jefferies | Hold |
2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
2022-11-18 | 개시 | Credit Suisse | Outperform |
2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
2022-01-03 | 재확인 | Bernstein | Mkt Perform |
2021-12-20 | 재확인 | Cowen | Outperform |
2021-12-17 | 개시 | Goldman | Neutral |
2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
2021-12-09 | 개시 | Wells Fargo | Overweight |
2021-11-19 | 개시 | BMO Capital Markets | Outperform |
2021-07-27 | 재개 | Truist | Buy |
2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2020-11-19 | 재개 | Goldman | Neutral |
2020-11-10 | 재개 | Bernstein | Mkt Perform |
2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
2020-09-29 | 개시 | Berenberg | Hold |
2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
2020-02-27 | 개시 | Barclays | Equal Weight |
2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
2020-02-06 | 개시 | Mizuho | Buy |
2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
2019-10-17 | 재개 | BofA/Merrill | Neutral |
2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2019-06-04 | 재개 | Morgan Stanley | Overweight |
2019-02-20 | 재개 | Citigroup | Neutral |
2019-01-31 | 업그레이드 | Argus | Hold → Buy |
2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Pfizer Cuts Last AAV Gene Therapy Program By Taking Beqvez Off The Market - News & Insights
Pfizer Jettisons FDA-Approved Hemophilia B Gene Therapy Beqvez - CGTLive™
Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes - Yahoo Finance
Pfizer shelves haemophilia gene therapy Beqvez amid low demand - Yahoo Finance
Pfizer: Investors Won't Stick Around Forever (NYSE:PFE) - Seeking Alpha
Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair - BioPharma Dive
Pfizer stops selling hemophilia gene therapy, citing weak demand - BioPharma Dive
An awkward moment for Pfizer’s Bourla in Washington - STAT
Topical Drug Delivery Market Booming Innovations & Forecast 2032 with Johnson & Johnson, Pfizer Inc., GSK plc, - EIN News
Is Pfizer Inc. (PFE) the Best Non-Tech Stock to Buy Now for Long Term? - Insider Monkey
Capital Advisory Group Advisory Services LLC Makes New $292,000 Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat
Bradley Foster & Sargent Inc. CT Purchases 139,215 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Health Rounds: Swabs as good as unpleasant speculum exam for detecting cancer-causing HPV - Marketscreener.com
Pfizer Inc. (NYSE:PFE) is WP Advisors LLC's 5th Largest Position - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Compass Capital Corp MA ADV Buys Shares of 49,457 Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer stops commercialization of hemophilia gene therapy Beqvez - Reuters
ING Groep NV Boosts Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Ieq Capital LLC Purchases 40,117 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Bryn Mawr Capital Management LLC - MarketBeat
#Pfizer has announced a strategic marketing and supply agreement with Mylan Pharmaceuticals. The deal aims to bolster distribution and sales of its two well-known brands, Ativan and Pacitane, in India. #Pharmaceuticals - linkedin
Sanctuary Advisors LLC Cuts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Ataxia Market Future Business Opportunities 2025-2032 | Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics - openPR
Principal Financial Group Inc. Has $169.90 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Trading Up 0%Still a Buy? - MarketBeat
Pfizer says it will end global development of hemophilia gene therapy Beqvez - TradingView
Pfizer nixes Roche-partnered hemophilia drug (PFE:NYSE) - Seeking Alpha
Pfizer says it will end global development of gene therapy Beqvez, Nikkei reports -February 20, 2025 at 02:58 pm EST - Marketscreener.com
Pfizer halts work on hemophilia gene therapy - Nikkei Asia
Pfizer (NYSE:PFE) Shares Up 0.1%Here's What Happened - MarketBeat
Pfizer's Big Game Ad Wins LinkedIn Member Poll - Pfizer
What's Driving the Market Sentiment Around Pfizer? - Benzinga
U.S. Diabetic Neuropathy Market to Witness Stunning Growth with Eli Lilly & Company, Johnson & Johnson - EIN News
Boston Financial Mangement LLC Increases Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
14,772 Shares in Pfizer Inc. (NYSE:PFE) Purchased by Advyzon Investment Management LLC - MarketBeat
First Bank & Trust Has $1.76 Million Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Davidson Investment Advisors Sells 100,344 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Handelsbanken Fonder AB Has $64.14 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Private Wealth Partners LLC Raises Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Cumberland Partners Ltd Acquires Shares of 76,600 Pfizer Inc. (NYSE:PFE) - MarketBeat
Private Advisor Group LLC Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Global Retirement Partners LLC Sells 24,744 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Vasopressin Market Is Booming Worldwide 2025-2032 | Par - openPR
Callahan Advisors LLC Purchases 69,155 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board of Directors for Breach of Fiduciary Duties (PFE) - TradingView
Trump to meet pharma leaders as they seek drug policy changes - Reuters
Pfizer (NYSE:PFE) Stock Price Down 0.6%Here's Why - MarketBeat
Pfizer (NYSE:PFE) Trading Up 0.9%Still a Buy? - MarketBeat
Pfizer (NYSE:PFE) Shares Up 0.1% on Insider Buying Activity - MarketBeat
TigerOak Management L.L.C. Purchases New Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):